Dorthe da Graça Thrige
Plus aucun poste en cours
Profil
Dorthe da Graça Thrige worked as Chief Operating Officer at Ascelia Pharma AB from 2012 to 2019.
Prior to that, she held positions as Director-Development at Active Biotech AB, Vice President-Clinical & Regulatory Affairs at CMC Contrast AB, and Head-Drug Discovery at AstraZeneca AB.
She received a graduate and doctorate degree from the University of Copenhagen.
Anciens postes connus de Dorthe da Graça Thrige
| Sociétés | Poste | Fin |
|---|---|---|
| ASCELIA PHARMA AB | Directeur des opérations | 31/12/2019 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
| ACTIVE BIOTECH AB | Corporate Officer/Principal | - |
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology CMC Contrast AB develops magnetic resonance contrast agents for patients suffering with tumors. Its product CMC 001 is a Manganese containing orally administered magnetic resonance imaging (MRI) contrast medium for enhancement of the liver, bile ducts and gastrointestinal tract. The company was founded by Henrik S. Thomsen in 2000 and is headquartered in Malmo, Sweden. | Directeur Technique/Scientifique/R&D | - |
Formation de Dorthe da Graça Thrige
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| ACTIVE BIOTECH AB | Health Technology |
| Entreprise privées | 2 |
|---|---|
CMC Contrast AB
CMC Contrast AB Pharmaceuticals: MajorHealth Technology CMC Contrast AB develops magnetic resonance contrast agents for patients suffering with tumors. Its product CMC 001 is a Manganese containing orally administered magnetic resonance imaging (MRI) contrast medium for enhancement of the liver, bile ducts and gastrointestinal tract. The company was founded by Henrik S. Thomsen in 2000 and is headquartered in Malmo, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |